Published mark
Idexx Laboratories
IDEXX LABORATORIES INC /DE
NASDAQ: IDXX. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db
- SEC CIK
- 0000874716
- Website
- www.idexx.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- Mar 27, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Jonathan J. MazelskyPresident and Chief Executive Officer
- Chair
- Not published
- Independent
- 4 / 55 directors published
- Published claims
- 535 distinct sources
- Evidence records
- 70 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 7 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Michael G. Erickson seat on Idexx Laboratories, effective 2026-01-01.
EffectiveEffective Jan 1, 2026E4
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and Chief Financial Officer | Andrew Emerson | Not captured | unknown | Source reportedE3 |
| President and Chief Executive Officer | Jonathan J. Mazelsky | Not captured | unknown | Source reportedE3 |
| Executive Vice President and Chief Technology Officer | Martin Smith | Not captured | unknown | Source reportedE3 |
| Executive Vice President and General Manager, CAG Diagnostics | Michael J. Lane | Not captured | unknown | Source reportedE3 |
| Executive Vice President, Global Strategy and Commercial | Tina Hunt | Not captured | unknown | Source reportedE3 |
Board of directors
Evidence5 directors published. 4 of 5 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Joseph L. Hooley | Independent | 2025 | AuditAudit; Governance and Corporate Responsibility; ESGESGGovernance and Corporate Responsibility | Source reportedE4 |
| Karen Peacock | Independent | 2025 | Compensation and TalentCompensation and Talent; FinanceFinance | Source reportedE4 |
| Michael G. Erickson | Not independent | 2026 | None published | Source reportedE4 |
| Sophie V. Vandebroek | Independent | 2013 | ESGFinanceGovernance and Corporate ResponsibilityGovernance and Corporate Responsibility; Finance; ESG | Source reportedE4 |
| Stuart M. Essig | Independent | 2017 | ESGFinanceGovernance and Corporate ResponsibilityGovernance and Corporate Responsibility; Finance; ESG | Source reportedE4 |
| Bruce L. Claflin | Independent | Not published | None published | Source reportedE3 |
| Bruce L. Claflin | Independence not published | Not published | AuditCompensation and Talent | Source reportedE5 |
| Daniel M. Junius | Independent | Not published | None published | Source reportedE3 |
| Daniel M. Junius | Independence not published | Not published | Audit, chairFinance | Source reportedE5 |
| Irene Chang Britt | Independent | Not published | None published | Source reportedE3 |
| Irene Chang Britt | Independence not published | Not published | AuditCompensation and Talent | Source reportedE5 |
| Jonathan J. Mazelsky | Not independent | Not published | None published | Source reportedE3 |
| Lawrence D. Kingsley | Independent | Not published | None published | Source reportedE3 |
| Lawrence D. Kingsley | Independence not published | Not published | Compensation and TalentESGGovernance and Corporate Responsibility | Source reportedE5 |
| Sam Samad | Independent | Not published | None published | Source reportedE3 |
| Sam Samad | Independence not published | Not published | AuditCompensation and Talent | Source reportedE5 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Daniel M. Junius | Daniel M. Junius, Bruce L. Claflin, Irene Chang Britt, Joseph L. Hooley, Sam Samad | Not described in the published record |
| Audit; Governance and Corporate Responsibility; ESG | Not published | Joseph L. Hooley | Not described in the published record |
| Compensation and Talent | Not published | Bruce L. Claflin, Irene Chang Britt, Karen Peacock, Lawrence D. Kingsley, Sam Samad | human_capital |
| Compensation and Talent; Finance | Not published | Karen Peacock | human_capital, financial |
| ESG | Not published | Joseph L. Hooley, Lawrence D. Kingsley, Sophie V. Vandebroek, Stuart M. Essig | Not described in the published record |
| Finance | Not published | Daniel M. Junius, Karen Peacock, Sophie V. Vandebroek, Stuart M. Essig | financial |
| Governance and Corporate Responsibility | Not published | Joseph L. Hooley, Lawrence D. Kingsley, Sophie V. Vandebroek, Stuart M. Essig | Not described in the published record |
| Governance and Corporate Responsibility; Finance; ESG | Not published | Sophie V. Vandebroek, Stuart M. Essig | financial |
Committee AppointmentDaniel M. Junius: chair, Audit
Committee AppointmentBruce L. Claflin: member, Audit
Committee AppointmentIrene Chang Britt: member, Audit
Committee AppointmentJoseph L. Hooley: member, Audit
Committee AppointmentSam Samad: member, Audit
Committee AppointmentBruce L. Claflin: member, Compensation and Talent
Committee AppointmentIrene Chang Britt: member, Compensation and Talent
Committee AppointmentKaren Peacock: member, Compensation and Talent
Committee AppointmentLawrence D. Kingsley: member, Compensation and Talent
Committee AppointmentSam Samad: member, Compensation and Talent
Committee RecordESG: Chair not stated; Members Joseph L. Hooley; Lawrence D. Kingsley; Sophie V. Vandebroek; Stuart M. Essig
Committee AppointmentJoseph L. Hooley: member, ESG
Committee AppointmentLawrence D. Kingsley: member, ESG
Committee AppointmentSophie V. Vandebroek: member, ESG
Committee AppointmentStuart M. Essig: member, ESG
Committee RecordFinance: Chair not stated; Members Daniel M. Junius; Karen Peacock; Sophie V. Vandebroek; Stuart M. Essig
Committee AppointmentDaniel M. Junius: member, Finance
Committee AppointmentKaren Peacock: member, Finance
Committee AppointmentSophie V. Vandebroek: member, Finance
Committee AppointmentStuart M. Essig: member, Finance
Committee RecordGovernance and Corporate Responsibility: Chair not stated; Members Joseph L. Hooley; Lawrence D. Kingsley; Sophie V. Vandebroek; Stuart M. Essig
Committee AppointmentJoseph L. Hooley: member, Governance and Corporate Responsibility
Committee AppointmentLawrence D. Kingsley: member, Governance and Corporate Responsibility
Committee AppointmentSophie V. Vandebroek: member, Governance and Corporate Responsibility
Committee AppointmentStuart M. Essig: member, Governance and Corporate Responsibility
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerJonathan J. Mazelsky, President and Chief Executive Officer
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Index MembershipNasdaq-100 (NDX)
Security ListingIDXX (NASDAQ)
Index memberships2 memberships attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPXNDX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NASDAQ: IDXX | current | Jan 5, 2017 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
| Nasdaq-100 (Nasdaq) | NASDAQ: IDXX | current | Sep 1, 2026 | exchange verified | Nasdaq official Nasdaq-100 list-type API |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameIDEXX LABORATORIES INC /DE
Entity StatusPublic listing published
Official Websitehttps://www.idexx.com
Published FactUS
Published FactDE
Published FactHealthcare
Published Facthttps://www.idexx.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Andrew EmersonExecutive Vice President and Chief Financial Officercompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:20
- Jonathan J. MazelskyPresident and Chief Executive Officer; Directorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:21, company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:12
- Martin SmithExecutive Vice President and Chief Technology Officercompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:22
- Michael J. LaneExecutive Vice President and General Manager, CAG Diagnosticscompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:23
- Tina HuntExecutive Vice President, Global Strategy and Commercialcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:24
- Joseph L. HooleyDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:13
- Karen PeacockDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:14
- Michael G. EricksonDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:16
- Sophie V. VandebroekDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:18
- Stuart M. EssigDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:19
- Bruce L. ClaflinDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:9
- Bruce L. ClaflinDirector (committee appointment)company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:committee_record:25
- Daniel M. JuniusDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:10
- Daniel M. JuniusDirector (committee appointment)company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:committee_record:25
- Irene Chang BrittDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:11
- Irene Chang BrittDirector (committee appointment)company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:committee_record:25
- Lawrence D. KingsleyDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:15
- Lawrence D. KingsleyDirector (committee appointment)company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:committee_record:31
- Sam SamadDirectorcompany:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:leadership_role:17
- Sam SamadDirector (committee appointment)company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db:committee_record:25
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 7 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
- E2IDEXX LABORATORIES INC /DE Form 10-K (filed 2026-02-20). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec def 14a. Published Mar 27, 2026. Retrieved Sep 14, 2026. Cited by 11 Claims.
- E4sec proxy. Published Mar 27, 2026. Retrieved May 3, 2026. Cited by 5 Claims.
- E5board_seats. sec def 14a. Cited by 27 Claims.
- E6Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
- E7Nasdaq official Nasdaq-100 list-type API. index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Michael G. Erickson seat on Idexx Laboratories, effective 2026-01-01.
- Joseph L. Hooley seat on Idexx Laboratories, effective 2025-01-01.
- Karen Peacock seat on Idexx Laboratories, effective 2025-01-01.
- Audit; Governance and Corporate Responsibility; ESG committee of Idexx Laboratories, effective 2025-01-01.
- Joseph L. Hooley member of Audit; Governance and Corporate Responsibility; ESG, effective 2025-01-01.
- Compensation and Talent; Finance committee of Idexx Laboratories, effective 2025-01-01.
- Karen Peacock member of Compensation and Talent; Finance, effective 2025-01-01.
- Stuart M. Essig seat on Idexx Laboratories, effective 2017-01-01.
- Stuart M. Essig member of Governance and Corporate Responsibility; Finance; ESG, effective 2017-01-01.
- Sophie V. Vandebroek seat on Idexx Laboratories, effective 2013-01-01.
- Governance and Corporate Responsibility; Finance; ESG committee of Idexx Laboratories, effective 2013-01-01.
- Sophie V. Vandebroek member of Governance and Corporate Responsibility; Finance; ESG, effective 2013-01-01.